Bone Biologics (BBLG) Shares Issued (2013 - 2024)

Bone Biologics (BBLG) reported Shares Issued of $287233.0 for Q3 2024, up 119.1% quarter-over-quarter from -$1.5 million in Q2 2024.

Bone Biologics (BBLG) Shares Issued (2013 - 2024) Analysis & Trends

Bone Biologics (BBLG) has 5 years of Shares Issued data on file, last reported at $287233.0 in Q3 2024.

Shares Issued for Q3 2024 came in at $287233.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $287233.0 (changed 0.15% YoY), and the FY2025 annual result was $4.4 million, up 657421.45% from the prior year.
Shares Issued grew to $287233.0 in Q3 2024 per BBLG's latest filing, from -$1.5 million in the prior quarter.
Over five years, Shares Issued peaked at $1.5 million in Q1 2024 and troughed at -$1.5 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	5.40 Mn
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	27.00 Mn
9	Abivax	95.45 Bn	95.45 Bn	-	26,927.15
10	Bone Biologics	1.47 Mn	1.47 Mn	-	-

Download Data